Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Animal Pharmaceutical Market Size Analysis from 2022 to 2027
1.5.1 Global Animal Pharmaceutical Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Animal Pharmaceutical Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Animal Pharmaceutical Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Animal Pharmaceutical Industry Impact
Chapter 2 Global Animal Pharmaceutical Competition by Types, Applications, and Top Regions and Countries
2.1 Global Animal Pharmaceutical (Volume and Value) by Type
2.1.1 Global Animal Pharmaceutical Consumption and Market Share by Type (2016-2021)
2.1.2 Global Animal Pharmaceutical Revenue and Market Share by Type (2016-2021)
2.2 Global Animal Pharmaceutical (Volume and Value) by Application
2.2.1 Global Animal Pharmaceutical Consumption and Market Share by Application (2016-2021)
2.2.2 Global Animal Pharmaceutical Revenue and Market Share by Application (2016-2021)
2.3 Global Animal Pharmaceutical (Volume and Value) by Regions
2.3.1 Global Animal Pharmaceutical Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Animal Pharmaceutical Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Animal Pharmaceutical Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Animal Pharmaceutical Consumption by Regions (2016-2021)
4.2 North America Animal Pharmaceutical Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Animal Pharmaceutical Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Animal Pharmaceutical Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Animal Pharmaceutical Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Animal Pharmaceutical Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Animal Pharmaceutical Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Animal Pharmaceutical Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Animal Pharmaceutical Sales, Consumption, Export, Import (2016-2021)
4.10 South America Animal Pharmaceutical Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Animal Pharmaceutical Market Analysis
5.1 North America Animal Pharmaceutical Consumption and Value Analysis
5.1.1 North America Animal Pharmaceutical Market Under COVID-19
5.2 North America Animal Pharmaceutical Consumption Volume by Types
5.3 North America Animal Pharmaceutical Consumption Structure by Application
5.4 North America Animal Pharmaceutical Consumption by Top Countries
5.4.1 United States Animal Pharmaceutical Consumption Volume from 2016 to 2021
5.4.2 Canada Animal Pharmaceutical Consumption Volume from 2016 to 2021
5.4.3 Mexico Animal Pharmaceutical Consumption Volume from 2016 to 2021
Chapter 6 East Asia Animal Pharmaceutical Market Analysis
6.1 East Asia Animal Pharmaceutical Consumption and Value Analysis
6.1.1 East Asia Animal Pharmaceutical Market Under COVID-19
6.2 East Asia Animal Pharmaceutical Consumption Volume by Types
6.3 East Asia Animal Pharmaceutical Consumption Structure by Application
6.4 East Asia Animal Pharmaceutical Consumption by Top Countries
6.4.1 China Animal Pharmaceutical Consumption Volume from 2016 to 2021
6.4.2 Japan Animal Pharmaceutical Consumption Volume from 2016 to 2021
6.4.3 South Korea Animal Pharmaceutical Consumption Volume from 2016 to 2021
Chapter 7 Europe Animal Pharmaceutical Market Analysis
7.1 Europe Animal Pharmaceutical Consumption and Value Analysis
7.1.1 Europe Animal Pharmaceutical Market Under COVID-19
7.2 Europe Animal Pharmaceutical Consumption Volume by Types
7.3 Europe Animal Pharmaceutical Consumption Structure by Application
7.4 Europe Animal Pharmaceutical Consumption by Top Countries
7.4.1 Germany Animal Pharmaceutical Consumption Volume from 2016 to 2021
7.4.2 UK Animal Pharmaceutical Consumption Volume from 2016 to 2021
7.4.3 France Animal Pharmaceutical Consumption Volume from 2016 to 2021
7.4.4 Italy Animal Pharmaceutical Consumption Volume from 2016 to 2021
7.4.5 Russia Animal Pharmaceutical Consumption Volume from 2016 to 2021
7.4.6 Spain Animal Pharmaceutical Consumption Volume from 2016 to 2021
7.4.7 Netherlands Animal Pharmaceutical Consumption Volume from 2016 to 2021
7.4.8 Switzerland Animal Pharmaceutical Consumption Volume from 2016 to 2021
7.4.9 Poland Animal Pharmaceutical Consumption Volume from 2016 to 2021
Chapter 8 South Asia Animal Pharmaceutical Market Analysis
8.1 South Asia Animal Pharmaceutical Consumption and Value Analysis
8.1.1 South Asia Animal Pharmaceutical Market Under COVID-19
8.2 South Asia Animal Pharmaceutical Consumption Volume by Types
8.3 South Asia Animal Pharmaceutical Consumption Structure by Application
8.4 South Asia Animal Pharmaceutical Consumption by Top Countries
8.4.1 India Animal Pharmaceutical Consumption Volume from 2016 to 2021
8.4.2 Pakistan Animal Pharmaceutical Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Animal Pharmaceutical Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Animal Pharmaceutical Market Analysis
9.1 Southeast Asia Animal Pharmaceutical Consumption and Value Analysis
9.1.1 Southeast Asia Animal Pharmaceutical Market Under COVID-19
9.2 Southeast Asia Animal Pharmaceutical Consumption Volume by Types
9.3 Southeast Asia Animal Pharmaceutical Consumption Structure by Application
9.4 Southeast Asia Animal Pharmaceutical Consumption by Top Countries
9.4.1 Indonesia Animal Pharmaceutical Consumption Volume from 2016 to 2021
9.4.2 Thailand Animal Pharmaceutical Consumption Volume from 2016 to 2021
9.4.3 Singapore Animal Pharmaceutical Consumption Volume from 2016 to 2021
9.4.4 Malaysia Animal Pharmaceutical Consumption Volume from 2016 to 2021
9.4.5 Philippines Animal Pharmaceutical Consumption Volume from 2016 to 2021
9.4.6 Vietnam Animal Pharmaceutical Consumption Volume from 2016 to 2021
9.4.7 Myanmar Animal Pharmaceutical Consumption Volume from 2016 to 2021
Chapter 10 Middle East Animal Pharmaceutical Market Analysis
10.1 Middle East Animal Pharmaceutical Consumption and Value Analysis
10.1.1 Middle East Animal Pharmaceutical Market Under COVID-19
10.2 Middle East Animal Pharmaceutical Consumption Volume by Types
10.3 Middle East Animal Pharmaceutical Consumption Structure by Application
10.4 Middle East Animal Pharmaceutical Consumption by Top Countries
10.4.1 Turkey Animal Pharmaceutical Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Animal Pharmaceutical Consumption Volume from 2016 to 2021
10.4.3 Iran Animal Pharmaceutical Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Animal Pharmaceutical Consumption Volume from 2016 to 2021
10.4.5 Israel Animal Pharmaceutical Consumption Volume from 2016 to 2021
10.4.6 Iraq Animal Pharmaceutical Consumption Volume from 2016 to 2021
10.4.7 Qatar Animal Pharmaceutical Consumption Volume from 2016 to 2021
10.4.8 Kuwait Animal Pharmaceutical Consumption Volume from 2016 to 2021
10.4.9 Oman Animal Pharmaceutical Consumption Volume from 2016 to 2021
Chapter 11 Africa Animal Pharmaceutical Market Analysis
11.1 Africa Animal Pharmaceutical Consumption and Value Analysis
11.1.1 Africa Animal Pharmaceutical Market Under COVID-19
11.2 Africa Animal Pharmaceutical Consumption Volume by Types
11.3 Africa Animal Pharmaceutical Consumption Structure by Application
11.4 Africa Animal Pharmaceutical Consumption by Top Countries
11.4.1 Nigeria Animal Pharmaceutical Consumption Volume from 2016 to 2021
11.4.2 South Africa Animal Pharmaceutical Consumption Volume from 2016 to 2021
11.4.3 Egypt Animal Pharmaceutical Consumption Volume from 2016 to 2021
11.4.4 Algeria Animal Pharmaceutical Consumption Volume from 2016 to 2021
11.4.5 Morocco Animal Pharmaceutical Consumption Volume from 2016 to 2021
Chapter 12 Oceania Animal Pharmaceutical Market Analysis
12.1 Oceania Animal Pharmaceutical Consumption and Value Analysis
12.2 Oceania Animal Pharmaceutical Consumption Volume by Types
12.3 Oceania Animal Pharmaceutical Consumption Structure by Application
12.4 Oceania Animal Pharmaceutical Consumption by Top Countries
12.4.1 Australia Animal Pharmaceutical Consumption Volume from 2016 to 2021
12.4.2 New Zealand Animal Pharmaceutical Consumption Volume from 2016 to 2021
Chapter 13 South America Animal Pharmaceutical Market Analysis
13.1 South America Animal Pharmaceutical Consumption and Value Analysis
13.1.1 South America Animal Pharmaceutical Market Under COVID-19
13.2 South America Animal Pharmaceutical Consumption Volume by Types
13.3 South America Animal Pharmaceutical Consumption Structure by Application
13.4 South America Animal Pharmaceutical Consumption Volume by Major Countries
13.4.1 Brazil Animal Pharmaceutical Consumption Volume from 2016 to 2021
13.4.2 Argentina Animal Pharmaceutical Consumption Volume from 2016 to 2021
13.4.3 Columbia Animal Pharmaceutical Consumption Volume from 2016 to 2021
13.4.4 Chile Animal Pharmaceutical Consumption Volume from 2016 to 2021
13.4.5 Venezuela Animal Pharmaceutical Consumption Volume from 2016 to 2021
13.4.6 Peru Animal Pharmaceutical Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Animal Pharmaceutical Consumption Volume from 2016 to 2021
13.4.8 Ecuador Animal Pharmaceutical Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Animal Pharmaceutical Business
14.1 Zoetis
14.1.1 Zoetis Company Profile
14.1.2 Zoetis Animal Pharmaceutical Product Specification
14.1.3 Zoetis Animal Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Merck
14.2.1 Merck Company Profile
14.2.2 Merck Animal Pharmaceutical Product Specification
14.2.3 Merck Animal Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Merial
14.3.1 Merial Company Profile
14.3.2 Merial Animal Pharmaceutical Product Specification
14.3.3 Merial Animal Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Elanco
14.4.1 Elanco Company Profile
14.4.2 Elanco Animal Pharmaceutical Product Specification
14.4.3 Elanco Animal Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Bayer Animal Health
14.5.1 Bayer Animal Health Company Profile
14.5.2 Bayer Animal Health Animal Pharmaceutical Product Specification
14.5.3 Bayer Animal Health Animal Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Boehringer Ingelheim Vetmedica
14.6.1 Boehringer Ingelheim Vetmedica Company Profile
14.6.2 Boehringer Ingelheim Vetmedica Animal Pharmaceutical Product Specification
14.6.3 Boehringer Ingelheim Vetmedica Animal Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Virbac
14.7.1 Virbac Company Profile
14.7.2 Virbac Animal Pharmaceutical Product Specification
14.7.3 Virbac Animal Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Ceva Sante Animale
14.8.1 Ceva Sante Animale Company Profile
14.8.2 Ceva Sante Animale Animal Pharmaceutical Product Specification
14.8.3 Ceva Sante Animale Animal Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Vtoquinol
14.9.1 Vtoquinol Company Profile
14.9.2 Vtoquinol Animal Pharmaceutical Product Specification
14.9.3 Vtoquinol Animal Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Jurox
14.10.1 Jurox Company Profile
14.10.2 Jurox Animal Pharmaceutical Product Specification
14.10.3 Jurox Animal Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 MSD Animal Health Australia
14.11.1 MSD Animal Health Australia Company Profile
14.11.2 MSD Animal Health Australia Animal Pharmaceutical Product Specification
14.11.3 MSD Animal Health Australia Animal Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 PARNELL
14.12.1 PARNELL Company Profile
14.12.2 PARNELL Animal Pharmaceutical Product Specification
14.12.3 PARNELL Animal Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 CAHIC
14.13.1 CAHIC Company Profile
14.13.2 CAHIC Animal Pharmaceutical Product Specification
14.13.3 CAHIC Animal Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Ringpu Biology
14.14.1 Ringpu Biology Company Profile
14.14.2 Ringpu Biology Animal Pharmaceutical Product Specification
14.14.3 Ringpu Biology Animal Pharmaceutical Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Animal Pharmaceutical Market Forecast (2022-2027)
15.1 Global Animal Pharmaceutical Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Animal Pharmaceutical Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Animal Pharmaceutical Value and Growth Rate Forecast (2022-2027)
15.2 Global Animal Pharmaceutical Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Animal Pharmaceutical Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Animal Pharmaceutical Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Animal Pharmaceutical Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Animal Pharmaceutical Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Animal Pharmaceutical Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Animal Pharmaceutical Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Animal Pharmaceutical Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Animal Pharmaceutical Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Animal Pharmaceutical Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Animal Pharmaceutical Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Animal Pharmaceutical Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Animal Pharmaceutical Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Animal Pharmaceutical Consumption Forecast by Type (2022-2027)
15.3.2 Global Animal Pharmaceutical Revenue Forecast by Type (2022-2027)
15.3.3 Global Animal Pharmaceutical Price Forecast by Type (2022-2027)
15.4 Global Animal Pharmaceutical Consumption Volume Forecast by Application (2022-2027)
15.5 Animal Pharmaceutical Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
